Mark Leiser

CHICAGO — Patient-facing resources about AI in cancer care are scarce, according to study results presented at ASCO Annual Meeting.

An analysis of cancer medicines approved in the past couple decades to treat adults with solid tumors revealed what investigators consider multiple troubling trends.

Use of innovative strategies designed to bring scientific research closer to where patients live may eliminate barriers that prevent some individuals

A class of medications widely prescribed to treat ADHD and narcolepsy can confer modest but consistent reductions in cancer-related fatigue, according to results of a systematic review and meta-analysis of randomized trials.

A global survey of clinicians who care for people with cancer revealed multiple potential barriers that likely hinder adoption of integrative oncology strategies.

One-fifth of cancer drugs initially denied coverage by Medicare Part D insurance plans ultimately received approval from independent reviewers after second-level appeal, according to study results.

A real-world study has identified what researchers believe is the optimal metric to determine the effectiveness of therapy for metastatic castration-sensitive prostate cancer.Patients whose PSA levels dropped below 0.2 ng/mL within 9 months of treatment initiation exhibited 54% lower risk for death than patients whose PSA did not fall below that level, a retrospective analysis of Veterans Health

Flight attendants and pilots have higher risks for radiation-related cancer deaths than individuals with other occupations, according to results of a cross-sectional study.

An updated clinical guideline is designed to clarify the settings in which radiation therapy is appropriate for pancreatic cancer and outline how the modality can be integrated safely with other treatments.

Risk-stratification models can help identify which hematopoietic cell transplant recipients are most likely to develop subsequent skin cancers, according to study results.